Apr 23, 2020 / 01:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the Lilly Q1 earnings conference call. (Operator Instructions) As a reminder, your conference call today is being recorded. I will now turn the conference call over to your host, Vice President of Investor Relations, Kevin Hern. Go ahead, please.
Kevin Hern - Eli Lilly and Company - VP of IR
Good morning. Thank you for joining us for Eli Lilly and Company's Q1 2020 Earnings Call. I'm Kevin Hern, Vice President of Investor Relations. Joining me on today's call are Dave Ricks, Lilly's Chairman and CEO; Josh Smiley, Chief Financial Officer; Dr. Dan Skovronsky, Chief Scientific Officer; Anne White, President of Lilly Oncology; Patrik Jonsson, President of Lilly Bio-Medicines; and Mike Mason, President of Lilly Diabetes. We're also joined by Sara Smith and Mike Czapar of the Investor Relations team.
In addition, I would like to welcome Anat Hakim, who recently joined Lilly as Senior Vice President and General Counsel. Anat joins Lilly with a wealth of experience in the health care industry, and more
Q1 2020 Eli Lilly and Co Earnings Call Transcript
Apr 23, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers